Trial
NCT01531803
Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients
Phase IVTERMINATEDREGULATORYConfidence: MEDIUM
Sponsor
Kedrion S.p.A.
Collaborators
inVentiv Health Clinical
Condition
Hypovolemia
Intervention
Kedbumin 25%
Why stopped
Per FDA CBER letter dated July 15, 2015, Kedrion SpA was released from the PMC to perform the study with Kedbumin 25% in pediatric patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-15